NAFDAC approves Oxford/AstraZeneca Covid-19 vaccine for use in Nigeria

The National Agency for Food and Drug Administration and Control (NAFDAC) has approved the Oxford/AstraZeneca Covid-19 vaccine for use in Nigeria.

This information was made public by the Personal Assistant on New Media to President Buhari, Bashir Ahmad, yesterday.

According to his statement, the Director-General of the agency, Dr. Mojisola Adeyeye made this decision based on the recommendation of the agency after rigorous scientific considerations conducted by NAFDAC.

Dr. Adeyeye noted that the review of the shot’s efficacy was conducted by NAFDAC after the agency received the “vaccine dossier” from Serum Institute of India on Feb. 10. “COVISHIELD was found safe and well-tolerated in adults above 18 years of age.

Related news

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.